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Abstract: Calophyllum brasiliense Cambess, Calophyllaceae, is of great interest 
in folk medicine and is used in the treatment of various diseases such as diabetes. 
Granules containing the hydroethanolic extract from the stem bark of C. brasiliense 
were obtained. The polyphenol content was standardized, and the average weight, 
disintegration, and the dissolution profi les of the capsules were determined after 
encapsulation. The capsules had an average weight of 574.5±8.0 mg. In vitro tests 
showed that the most effi cient disintegration profi le was in hydrochloric acid buffer 
(pH 1.2), with a capsule disintegration time within 9 min. The dissolution analysis 
showed a better uniformity of capsule content release when the test was performed in 
a hydrochloric acid buffer (pH 1.2), with a maximal release rate at 15 min (giving a 
polyphenol content of 4.38%, which corresponds to a concentration of 0.0080 mg/mL). 
In distilled water, the maximal release was reached at 20 min (giving a polyphenol 
content of 5.41%, which is equivalent to 0.0105 mg/mL). In phosphate buffer, the 
maximal release of capsule contents was reached at the end of the dissolution assay (30 
min), with the lowest amount of released polyphenols (3.61%, which corresponds to a 
concentration of 0.0070 mg/mL). The encapsulated form of the hydroethanolic extract 
of C. brasiliense was shown to have the necessary traits of a desirable delivery agent, 
and the dissolution test was an effective analysis of this material’s polyphenol release 
profi le for the specifi c dosage form.
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Introduction
 The evolution of organic chemistry has allowed 
the large-scale production of synthetic compounds for 
therapeutic applications. Because these compounds are 
modularly produced by organic synthesis, molecular 
modifications that improve the activity and therapeutic 
potency of these drugs have been possible. However, 
interest in plant products for therapeutic applications 
has recently increased due to the many side effects 
caused by synthetic drugs, the high cost of drug therapy, 
the difficulty encountered by the pharmaceutical 
industry in developing new synthetic therapeutic 
agents, the high cost of research and production of new 
biologically active molecules, and the growing demand 
for medicinal plants with pharmacological activity 
(Capasso, 2000; Rates, 2000; Niero et al., 2003). 
 Medicinal plants facilitate the development 
and production of new drugs in a shorter period of 
time because researchers already have clues on the 
biological activities of a plant based on the history of 
its use by the general population prior to beginning 
research. (Funari & Ferro, 2005).
 Calophyllum brasiliense Cambess, 
Calophyllaceae (Cb) is known by several common 
names, including “jacareúba”, “guanandi”, “guanandi-
carvalho”, “cedro-do-pântano”, and “landim”, among 
others (Pereira, 1966). In folk medicine, this plant has 
been used for the treatment of various diseases such 
as bronchitis, liver and gastrointestinal disorders, 
pain, inflammation, diabetes, hypertension, diarrhea, 
rheumatism, hemorrhoids, varicose veins, and herpes 
(Silva et al., 2001).
 Pharmacological studies on this species are 
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scarce; however, the extract of this plant has been 
shown to display antiretroviral activity (Huerta-Reyes 
et al., 2004), as well as activity against the Trypanosoma 
cruzi parasite (Abe et al., 2004), Bacillus cereus, and 
Staphylococcus epidermidis (Cottiglia et al., 2004). 
The extract from the stem bark has also been shown to 
possess gastroprotective, anti-ulcer, and cytoprotective 
effects (Sartori et al., 1999). In addition, anti-neoplastic 
activity has been reported for brasixanthones present in 
the stem extract (Ito et al., 2003). Furthermore, some 
coumarins and xanthones of the extract have shown an 
inhibitory effect on the release of stomach acid (Reyes-
Chilpa et al., 2006).
 Herbal medicines derived from plants are 
produced by the appropriate technological processes 
using only plant material as the source for biologically 
active compounds. The production of herbal medicines 
is based on formulations developed from parts of the 
plant that are able to keep their phytochemical integrity 
during the production process (Carvalho, 2004).
 Plant products are standardized based on 
the concentration of a single active compound. This 
compound, called a chemical marker, ensures the 
high quality of the plant material and uniformity of its 
biological activity. A method for ensuring uniformity is 
to obtain a profile of all significant known and unknown 
chemical compounds in the plant (Perrone et al., 2012). 
A method for the quantification of total polyphenol 
content was reported by Swain & Hillls (1959). This 
method is used already to tannin quantification, it is 
based on the reduction of phosphomolybdic tungstic 
acid by phenolic hydroxyl groups, producing a dark 
color complex in alkaline medium that absorbs in the 
visible spectrum (λ = 620 to 760 nm).
 Based on the importance of the pharmacological 
applications of Cb, we formulated and studied the granular 
of the hydroethanolic extract from the stem bark of 
Calophyllum brasiliense (HEECb) to standardize the 
products from this plant.
Material and Methods
Collection of plant material
 The stem bark of the Calophyllum brasiliense 
Cambess, Calophyllaceae, plant was collected in the 
city of Ferreira Gomes (native area), Amapá, Brazil. 
The botanical fertilized material was identified in 
the herbarium of the Amapá State Research Institute 
(Instituto de Pesquisa Científicas e Tecnológicas do 
Amapá, Voucher number 0598AP).
Production of hydroethanolic extract
 The HEECb were obtained by crushing and 
grinding 2 kg Cb bark macerated in percolator model 
LM20 (Lemaq Ltda, São Paulo, Brazil) with 70% (v/v) 
aqueous ethanol at 45 °C for four days at a ratio of 
1:8 (w/v). The extraction solution was filtered through 
filter paper and concentrated to dryness using a rotary 
evaporator model Q.218.2 (Quimis Ltda, São Paulo, 
Brazil) at 70 °C and 530 mmHg. The final yield was 
31%.
Production of granules
 Granules were obtained by manual mixture wet 
granulation using the following combination of extract 
and excipients: 21.80% cellulose Avicel® (Sigma-Aldrich 
Co., St. Louis, USA), 3.87% magnesium stearate Riedel-
de Haën® (Sigma-Aldrich Co., St. Louis, USA), 33.35% 
D-lactose monohydrate Vetec® (Vetec Química Fina Ltda, 
Rio Janeiro, Brazil) 9.06% corn starch Duryea® (Unilever 
Brazil Industrial Ltda, Pernambuco, Brazil), 5.28% water 
and 26.64% dry HEECb.
Production of capsules 
 Gelatin capsules (size 1) were used to manually 
encapsulate the granules. To control the amount of 
encapsulated plant material, the average weight was 
determined using the following equation:
 
where: Tec: extract content in the capsules; Mmc: 
average mass of the capsule (g); Meg: mass of extract 
in the granules (g); Mtg: total mass of granules (g).
Average weight
 The average weight was determined based on the 
methodology described in the Brazilian Pharmacopoeia 
(F. Bras. V, 2010). The weights of twenty capsules were 
determined.
Disintegration test
 The disintegration test was performed in a 
capsule disintegrator model 301/3AC (Nova Ética, 
Ltda. São Paulo, Brazil) that contained three separate 
vessels. Six capsules were placed in each vessel. 
Destiled water (DW), hydrochloric acid buffer (HAB) 
pH 1.2 and phosphate buffer (PB) pH 6.8 were used as 
immersion liquids. The disintegration time was defined 
as the time required for the total disintegration of the 
capsules (F. Bras. V, 2010).
Mtg
MegMmcTec .
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Dissolution test
 The dissolution test was carried out in a 
dissolution apparatus with three vessels model 299 
(Nova Ética, Ltda. São Paulo, Brazil) at a stirring speed 
of 75 rpm. In each vessel, 800 mL HAB pH 1.2, PB 
pH 6.8, or DW was used as a dissolution medium. All 
tanks were kept at 37±1ºC. Total polyphenol contents 
were used as a marker for the HEECb, and assays were 
performed with six replicates for each dissolution 
medium.
 The dissolution profiles were determined based 
on the quantification of total polyphenol content from the 
capsules dissolved in the dissolution vessels at 5, 10, 15, 
20, and 30 min. Aliquots of 3 mL were filtered through 
filter paper (12.5 cm diameter, 80 g/m²), and 2.5 mL 
filtered samples were used to measure the amount of total 
polyphenols using a spectrophotometer model UVmini-
1240 (Shimadzu Corporation, Kyoto, Japan) at 760 nm, 
based on the adapted methodology described by Sousa 
(2009) and Farmacopeia Brasileira (2010).
 The polyphenol content was determined by 
triplicate based on the equation for the pyrogallic acid 
standard curve at concentrations ranging from 0.01 to 
0.05 mg/mL resulting from absorbance values measured 
after the reaction with the phosphomolybdic tungstic 
acid in alkaline medium (Figure 1).
 
Figure 2. Pyrogallic acid standard curve at concentrations 
ranging from 0.01 to 0.05 mg/mL. Pyrogallic acid was reacted 
with phosphomolybdic tungstic acid in alkaline medium, and 
the absorbance of the product mixture was measured at 760 
nm.
 The polyphenol concentration was obtained 
as a percentage using the equation described by Sousa 
(2009):
 
%Pf: percentage of polyphenols; x: sample concentration 
based on the linear regression equation; QLC: quantity of 
liquid in the vessel; M: mass of extract in tablets.
Statistical analysis
 Each result was analyzed by one-way ANOVA 
followed by a linear regression test. Comparative 
analysis of the dissolution profiles was performed 
using the Student-Newman-Keuls t-test, and results 
with p values <0.05 were considered significant. All 
statistical analysis was performed using GraphPad 
Instat® and Prism® software (version 5.03).
Results and Discussion
 Combining the granules with excipients 
that have different physicochemical properties in a 
pharmaceutical formulation may affect drug dissolution 
and disintegration, which would in turn affect the 
speed of absorption and the bioavailability (Gibaldi, 
1991). Therefore, the pharmacological characteristics 
of the excipients were considered during the granule 
production to present a mixture within the desired 
parameters for in vitro tests.
 Some of drug formulation components, such as 
starch and other disintegrants favor dissolution; however, 
components such as magnesium stearate, which acts 
as a lubricant, hamper dissolution and must be added 
in small amounts (Gibaldi, 1991). The high content 
of disintegrants and diluents were used to promote 
the rapid bioavailability of the extracts by dissolution 
and to accelerate the breakdown of the granules. The 
small amount of magnesium stearate contributed to the 
controlled release of the extract to reduce the attractive 
forces between particles, preventing agglomeration and 
segregation of the material due to its small size (Kibbe, 
2000; Thompson, 2006; Ansel et al., 2007).
 The formulation of the granule containing 
the HEECb used the following excipients: cellulose, 
magnesium stearate, D-lactose monohydrate, and 
cornstarch. These excipients showed effective solubility 
and dissolution, favoring the bioavailability of the 
HEECb through gradual and controlled release in the 
analyzed media (Table 1, Figures 3).
Table 1. Mass and percentage composition of the final granule 
developed by wet granulation.
Resulting granule Mass (g) Percentage
Excipients 207.400 68.085%
HEECb 81.120 26.630%
Water 16.104 5.285%
Total 304.624 100%
)(
100.).(
%
mgM
QLC
mL
mgx
Pf  Pf
g
g .mL
Study of dissolution profiles and desintegration of capsules containing the 
dried hydroethanolic extract of Calophyllum brasiliense
Helison de O. Carvalho et al.
Rev. Bras. Farmacogn. Braz. J. Pharmacogn. 23(1): Jan./Feb. 2013 197
 Regarding weight variation, the capsules 
were within the accepted standards of the Brazilian 
Pharmacopoeia (F. Bras. V, 2010), which states that 
capsule weight can vary by up to 7.5% for capsules 
over 300 mg, and no more than two capsules should 
exceed these parameters. All of the analyzed capsules 
had an average weight of 574.5±8.0 mg, with an 
acceptable range from 531.42 mg to 617.58 mg, the 
maximum and minimum weight values of capsules 
were 587 mg and 560 mg, respectively (Figure 2). 
Thus, none of the analyzed capsules containing HEECb 
granules exceeded the acceptable range. Based on the 
average weight, the extract content in each capsule was 
calculated by the previously described method to be 
0.153±0.008 g/capsule.
 
Figure 2. Determination of the weight of capsules containing 
HEECb granules. AUL corresponds to the acceptable upper 
limit of 7.5%, TAW corresponds to the theoretical average 
weight, and ALL corresponds to the acceptable lower limit 
of 7.5%.
 Disintegration is a very important step for the 
drug bioavailability and absorption. In order for the 
capsules to disintegrate efficiently, the active compound 
must be solubilized and totally disaggregated, 
consisting only of small particles (Ansel et al., 2007). 
The disintegration test of the capsules showed the 
rapid disintegration of the encapsulated granules, and 
the capsules were more efficiently disintegrated in the 
HAB (pH 1.2), with total disintegration occurring by 
9 min. The disintegration in DW and in (pH 6.8) were 
also rapid, but they were still slower than in the HAB, 
with total disintegration occurring by 13 and 18 min, 
respectively (Table 2).
Table 2. Disintegration time (in min) of the capsules in 
different disintegration media (n = 6).
Dissolution media Disintegration (min)
Distilled water 13
Hydrochloric acid buffer (pH 1.2) 9
Phosphate buffer (pH 6.8) 18
 The absorption of drugs delivered in a solid 
dosage form in physiological media depends on the 
dissociation of the active substance contained in the 
drug formulation. The release of the drug from its 
solid form involves three basic stages: disintegration, 
disaggregation, and dissolution (Adams et al., 2001). In 
vitro dissolution is very important to evaluate for drug 
performance, and these results can be correlated with 
the results of in vivo experiments (Amidon et al., 1995). 
Therefore, it is essential to control the experimental 
conditions to ensure reliability and reproducibility of 
the test.
 The dissolution test showed that the capsules 
performed best in HAB (pH 1.2), with a maximal release 
reached at 15 min and an HEECb polyphenol content 
of 4.38% (0.0080 mg/mL) at the end of dissolution 
assay (Figure 3). In DW, the maximal release occurred 
at 20 min and became stable thereafter. However, the 
polyphenol content in DW reached values above the 
polyphenol content in HAB (5.41%, which is equivalent 
to 0.0105 mg/mL) (Figure 3). PB (pH 6.8) showed the 
lowest amount of dissolution, reaching a maximal 
release at the end of the analysis (at 30 min) and having 
a low polyphenol content (3.61%, which corresponds 
to concentration of 0.0070 mg/mL) (Figure 3).
Figure 3. Dissolution time profile of the capsules (n=6) 
in distilled water (DW), hydrochloric acid buffer (HAB, 
pH 1.2), and phosphate buffer (PB, pH 6.8). Samples were 
reacted with phosphomolybdic tungstic acid in alkaline 
medium and analyzed at 760 nm. Comparison analysis of the 
dissolution profiles performed using Student-Newman-Keuls 
t-test. *p<0.05, **p<0.01, ***p<0.001. (a) compared to PB, 
(b) compared to HAB, (c) compared to DW.
 Each of the different dissolution media 
presented significant amounts of dissolved HEECb 
polyphenols after 10 min. DW medium showed the 
best dissolution profile. However, HAB showed a 
higher amount of HEECb polyphenols at 15 min 
compared to DW and PB (p<0.05). At 20 min, PB was 
the most inefficient dissolution medium, and at the end 
of the dissolution assay, DW and HAB showed higher 
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maximal release values of HEECb polyphenols. PB 
showed an ineffective dissolution profile, with a small 
increase at 30 min (Figure 3).
 Based on the times observed in the dissolution 
assay, DW showed the best ability to release 
polyphenols. DW was the most suitable medium for 
polyphenol extraction due to the variation of phenolic 
compounds’ solubility according to the polarity of 
the solvent used and the degree of polymerization of 
these compounds. The solvents commonly used for 
this purpose are methanol, ethanol, acetone, water, and 
propanol, among others (Naczk, 2004). Considering 
the release level of total polyphenols in HAB, which 
showed a significant difference compared to DW, HAB 
was the medium that showed the best uniform release 
of the HEECb marker, regardless of dissolution time. 
However, both DW and HAB demonstrated effective 
dissolution rates that may correlate with their in vivo 
performances.
Conclusion
 Calophyllum brasiliense was effectively 
extracted by hydroethanolic, and the efficiency 
of granule formulation was demonstrated by the 
dissolution profile of the polyphenols used here as a 
phytochemical marker. The marker was best released 
in hydrochloric acid buffer and destiled water, based on 
the average weight and the results of the disintegration 
tests, the developed capsule was within the standards 
recommended by the Brazilian Pharmacopoeia (F. Bras. 
V, 2010).
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